U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Acute monocytic leukemia

MedGen UID:
7319
Concept ID:
C0023465
Neoplastic Process
Synonyms: Acute Monoblastic Leukemia; Acute Monoblastic Leukemias; Acute Monocytic Leukemia; Acute Monocytic Leukemias; Leukemia, Acute Monocytic; Leukemia, Monoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute, M5; Leukemia, Myeloid, Schilling Type; Leukemia, Myeloid, Schilling-Type; Leukemia, Schilling-Type Myeloid; Leukemias, Acute Monoblastic; Leukemias, Acute Monocytic; Monoblastic Leukemia, Acute; Monoblastic Leukemias, Acute; Monocytic Leukemia, Acute; Monocytic Leukemias, Acute; Myeloid Leukemia, Acute, M5; Myeloid Leukemia, Schilling Type; Myeloid Leukemia, Schilling-Type; Schilling-Type Myeloid Leukemia
SNOMED CT: Acute monocytic leukemia, morphology (22331004); Acute monocytic leukemia (22331004); Acute monoblastic leukemia (22331004); FAB M5 (22331004)
Modes of inheritance:
Not genetically inherited
MedGen UID:
988794
Concept ID:
CN307044
Finding
Source: Orphanet
clinical entity without genetic inheritance.
 
HPO: HP:0004845
Monarch Initiative: MONDO:0007896
OMIM®: 151380
Orphanet: ORPHA514

Definition

The accumulation of transformed primitive hematopoietic blast cells, which lose their ability of normal differentiation and proliferation. [from HPO]

Clinical features

From HPO
Acute monocytic leukemia
MedGen UID:
7319
Concept ID:
C0023465
Neoplastic Process
The accumulation of transformed primitive hematopoietic blast cells, which lose their ability of normal differentiation and proliferation.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAcute monocytic leukemia

Conditions with this feature

Acute monocytic leukemia
MedGen UID:
7319
Concept ID:
C0023465
Neoplastic Process
The accumulation of transformed primitive hematopoietic blast cells, which lose their ability of normal differentiation and proliferation.
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
MedGen UID:
321945
Concept ID:
C1832388
Disease or Syndrome
RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an increased risk of developing a hematologic malignancy. RUNX1-FPDMM is characterized by thrombocytopenia with normal platelet size; bleeding is often greater than expected due to qualitative platelet dysfunction. Myeloid malignancies are the most common, including acute myelogenous leukemia (and myelodysplastic syndrome. T- and B-cell acute lymphoblastic leukemias and lymphomas have also been reported, as well as skin manifestations (e.g., eczema, psoriasis).
Neutropenia, severe congenital, 1, autosomal dominant
MedGen UID:
348506
Concept ID:
C1859966
Disease or Syndrome
ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia. In congenital neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony-stimulating factor treatment, the risk of developing myelodysplasia (MDS) or acute myelogenous leukemia (AML) is approximately 15%-25%. Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts. Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, affected individuals are generally healthy. Symptoms improve in adulthood. Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia.

Professional guidelines

PubMed

Anami Y, Deng M, Gui X, Yamaguchi A, Yamazaki CM, Zhang N, Zhang CC, An Z, Tsuchikama K
Mol Cancer Ther 2020 Nov;19(11):2330-2339. Epub 2020 Sep 2 doi: 10.1158/1535-7163.MCT-20-0407. PMID: 32879051Free PMC Article
Gonzalez CL, Jaffe ES
Oncology (Williston Park) 1990 Nov;4(11):47-60; discussion 60, 62. PMID: 2150325
McKenna RW, Bloomfield CD, Dick F, Nesbit ME, Brunning RD
Blood 1975 Oct;46(4):481-94. PMID: 169929

Recent clinical studies

Etiology

Ye M, Chen Y, Wang Y, Xiao L, Lin Q, Lin H, Duan Z, Feng S, Cao Y, Zhang J, Li J, Hu J
Spectrochim Acta A Mol Biomol Spectrosc 2022 Apr 15;271:120865. Epub 2022 Jan 7 doi: 10.1016/j.saa.2022.120865. PMID: 35063821
Xing S, Wang B, Gao Y, Li M, Wang T, Sun Y, Shen Y, Chao H
Int J Lab Hematol 2019 Aug;41(4):485-492. Epub 2019 May 17 doi: 10.1111/ijlh.13030. PMID: 31099482
Ge Y, Elghetany MT
Lab Hematol 2005;11(1):31-7. doi: 10.1532/LH96.04056. PMID: 15790550
Cline MJ
Blood 1994 Nov 1;84(9):2840-53. PMID: 7524755
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C
Br J Haematol 1976 Aug;33(4):451-8. doi: 10.1111/j.1365-2141.1976.tb03563.x. PMID: 188440

Diagnosis

Matarraz S, Almeida J, Flores-Montero J, Lécrevisse Q, Guerri V, López A, Bárrena S, Van Der Velden VHJ, Te Marvelde JG, Van Dongen JJM, Orfao A
Cytometry B Clin Cytom 2017 May;92(3):218-227. Epub 2015 Aug 18 doi: 10.1002/cyto.b.21219. PMID: 26282340
Zhang YY, Huang SH, Zhou HR, Chen CJ, Tian LH, Shen JZ
Oncol Rep 2016 Dec;36(6):3113-3122. Epub 2016 Oct 4 doi: 10.3892/or.2016.5147. PMID: 27748863Free PMC Article
Ru YX, Dong SX, Zhao SX, Liang HY, Wang HJ, Hu X, Mi YC, Wang JX
Ultrastruct Pathol 2016;40(1):18-23. doi: 10.3109/01913123.2015.1120838. PMID: 26771450
Schmalzl F
Haematol Blood Transfus 1981;27:145-56. doi: 10.1007/978-3-642-81696-3_16. PMID: 6948754
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C
Br J Haematol 1976 Aug;33(4):451-8. doi: 10.1111/j.1365-2141.1976.tb03563.x. PMID: 188440

Therapy

Guo H, Lin SY, Ren WX, Lei Q, Chen ZC, Zhang L, Li QB
Curr Med Sci 2018 Feb;38(1):35-42. Epub 2018 Mar 15 doi: 10.1007/s11596-018-1838-9. PMID: 30074149
Fang JF, Yuan HN, Song YF, Sun PB, Zheng XL, Wang XJ
Chin Med J (Engl) 2017 Jun 20;130(12):1481-1490. doi: 10.4103/0366-6999.207474. PMID: 28584213Free PMC Article
He X, Wang J, Li M, Hao D, Yang Y, Zhang C, He R, Tao R
J Ethnopharmacol 2014;151(1):78-92. Epub 2013 Dec 1 doi: 10.1016/j.jep.2013.11.023. PMID: 24296089
Smith MA, Rubinstein L, Ungerleider RS
Med Pediatr Oncol 1994;23(2):86-98. doi: 10.1002/mpo.2950230205. PMID: 8202047
Ohno S, Yokoo T, Ohta M, Yamamoto M, Danno K, Hamato N, Tomii K, Ohno Y, Kobashi Y
J Am Acad Dermatol 1990 Feb;22(2 Pt 2):374-7. doi: 10.1016/0190-9622(90)70052-j. PMID: 2406302

Prognosis

Wu J, Xiao Y, Sun J, Sun H, Chen H, Zhu Y, Fu H, Yu C, E W, Lai S, Ma L, Li J, Fei L, Jiang M, Wang J, Ye F, Wang R, Zhou Z, Zhang G, Zhang T, Ding Q, Wang Z, Hao S, Liu L, Zheng W, He J, Huang W, Wang Y, Xie J, Li T, Cheng T, Han X, Huang H, Guo G
J Hematol Oncol 2020 Sep 25;13(1):128. doi: 10.1186/s13045-020-00941-y. PMID: 32977829Free PMC Article
Xing S, Wang B, Gao Y, Li M, Wang T, Sun Y, Shen Y, Chao H
Int J Lab Hematol 2019 Aug;41(4):485-492. Epub 2019 May 17 doi: 10.1111/ijlh.13030. PMID: 31099482
Zhang YY, Huang SH, Zhou HR, Chen CJ, Tian LH, Shen JZ
Oncol Rep 2016 Dec;36(6):3113-3122. Epub 2016 Oct 4 doi: 10.3892/or.2016.5147. PMID: 27748863Free PMC Article
Ge Y, Elghetany MT
Lab Hematol 2005;11(1):31-7. doi: 10.1532/LH96.04056. PMID: 15790550
Cline MJ
Blood 1994 Nov 1;84(9):2840-53. PMID: 7524755

Clinical prediction guides

Bai J, Wang J, Yang Y, Wang F, He A, Zhang W
J Immunother 2021 May 1;44(4):141-150. doi: 10.1097/CJI.0000000000000350. PMID: 33596023
Sawa-Wejksza K, Dudek A, Lemieszek M, Kaławaj K, Kandefer-Szerszeń M
Tumour Biol 2018 Sep;40(9):1010428318797880. doi: 10.1177/1010428318797880. PMID: 30183516
Chiew MY, Boo NY, Voon K, Cheong SK, Leong PP
Leuk Lymphoma 2017 Jan;58(1):162-170. Epub 2016 May 17 doi: 10.1080/10428194.2016.1180683. PMID: 27185517
Zhang YY, Huang SH, Zhou HR, Chen CJ, Tian LH, Shen JZ
Oncol Rep 2016 Dec;36(6):3113-3122. Epub 2016 Oct 4 doi: 10.3892/or.2016.5147. PMID: 27748863Free PMC Article
Hilden JM, Kersey JH
Leuk Lymphoma 1994 Jul;14(3-4):189-95. doi: 10.3109/10428199409049668. PMID: 7950907

Recent systematic reviews

Fang JF, Yuan HN, Song YF, Sun PB, Zheng XL, Wang XJ
Chin Med J (Engl) 2017 Jun 20;130(12):1481-1490. doi: 10.4103/0366-6999.207474. PMID: 28584213Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...